PHARMEXA

Chemical products for use in the development of pharmaceuticals, vaccines, namely, therapeutic, subcomponent, polypeptide and live vaccines, viral and nucleic acids vaccines, DNA vaccines, vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science; chemical preparations for analyses in laboratories for in vivo analyses for medical purposes; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including DNA for vaccine use

Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; vaccines, namely, therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines and DNA vaccines, vaccine recipients, vaccine carriers, vaccines adjuvants; vaccines containing non-pathogenic microorganisms and vira; vaccines containing polypeptides, protein and nucleic acids, including DNA

Scientific, industrial biotechnological and biomedical research; pharmaceutical, biomedical and biotecnological development of therapeutic vaccines, other vaccines and pharmaceuticals; chemical, biochemical and molecular biological analyses; medical and scientific research, namely, in vitro and in vivo preclinical tests of potential drugs; medical and scientific research, namely, in vitro and in vivo research concerning therapeutic vaccines, other vaccines and potential drugs; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research